improperly treated or inadequately investigated, without their help. And so I shall speak mainly about the methods that are of direct clinical importance. Even so, I shall need to illustrate rather than to enumerate all the present applications of radioisotopes in clinical medicine. I will be dealing in particular with radioactive iodine, which was one of the first to be produced, and to be used in therapy, and which is one in which my own department has been interested. It is perhaps a fitting example, also, since it has important applications to the investigation and surgery of the thyroid gland, which Robert Campbell so much advanced by his surgical skill and published work.
I would like to start by explaining the meaning of some of the rather unfamiliar terms that are used in this subject, and those of you who are accustomed to work with isotopes and their radiations will, I hope, excuse this. So, firstly, what exactly is an isotope? You will remember, perhaps, that different atoms differ, not only in the weight of their nuclei, but also in the size of the electrical charges on them. Now it is the nuclear charge, and not the nuclear weight, which determines the chemical properties of the atom. For example, any atom with a charge of 53 units on the nucleus will have 53 electrons in their orbits round the nucleus, and these will give it the chemical properties of iodine, whatever the nuclear weight may happen to be. In fact, we know of atoms of every atomic weight from 124 to 137, but all having a charge of 53, so that all these different atoms are forms of iodine, and are known as its isotopes (Table I) . Now, only one of these iodines, that with atomic weight 127, is stable; all the rest are unstable, and undergo radioactive decay more or less rapidly. It is thus only iodine 127 that normally occurs in the thyroid or in nature. But the other and radioactive isotopes can be prepared by physical methods, for example, in the plutonium pile. The most convenient for clinical purposes is iodine 131, of which half undergoes radioactive decay within every eight days. In just the same way, radioactive forms of sodium, carbon, phosphorus, potassium and most other important elements are available, and all of them are chemically indistinguishable from the corresponding normal elements. Now the advantages of this are evident. We can give a dose of radioactive iodine in the knowledge that the body cannot distinguish it chemically from ordinary iodine; it will go exactly where ordinary iodine is going, it will be metabolised at the same rate, and will be shared between thyroid and kidney in the same proportion as for ordinary iodine. Yet, although its chemical metabolism is identical, its presence can be detected by means of its radioactivity with very great sensitivity; or, if large quantities are given, its radiations can be utilised to produce intense local radiation and tissue destruction at the sites where the 18 isotope is most highly concentrated. These radioactive iodine atoms form, in fact, the perfect "fifth column"; we send them out in uniforms which make them indistinguishable from the enemy, with whom they mix and move freely; and we equip them with wireless transmitters, so that they can signal their movements, and therefore his movements, continuously. Or, if we send out large numbers, they return with the enemy to all his sites of concentration and proceed to blow them up.
XVe must distinguish between these r6les of intelligence and sabotage, between our use of the isotope's radioactivity for its detection or for tissue destruction at the sites where it is selectively concentrated. And with radioiodine this distinction is clear-cut, since it requires about one thousand times as much of the isotope to cause effective tissue destruction as it does to allow useful measurement of thyroid function. (Table II It will be seen that the diagnostic tests with which we shall be concerned require only small fractions of a millicurie, whereas radioiodine therapy requires many millicuries. I should mention that a millicurie of any radioisotope is the amount in which atomic disintegrations are occurring as frequently as in a millicurie of radium, that is, in a milligram of radium in equilibrium with its products; so that in each millicurie of any radioactive isotope, about forty million atomic disintegrations are occurring each second. With the test doses of radioiodine, the irradiation outside the thyroid is quite negligible, and even within the thyroid it may be no higher than is received by large areas of the body during two minutes' X-ray screening after a barium meal or in the chest clinic. To the patient, the radiation hazard of the smaller test doses at least is as negligible as in many routine radiodiagnostic procedures. Rather larger test doses are needed to map out the distribution of iodine within the thyroid gland or in the neck, but they are still withlout detectable effect on thyroid or any other function. Even at the much 19 higher level of dosage for therapy in Graves's disease, where the thyroid will receive several thousand rcentgens of irradiation, blood changes are not normally seen and the menstrual periods are undisturbed; and they are normally uninfluenced even by the higher doses still that are required for thyroid carcinomata, which do, however, produce a transient depression of the blood lymphocyte count, lasting for perhaps a fortnight.
Let us consider in turn the uses of isotopes for simple tests of function, for mapping the distribution of elements within the body, and for various types of therapy.
I will illustrate first how a radioactive isotope can be used to give a simple measure of thyroid function. When radioiodine is taken by mouth, most of what is lost from the body is excreted in the urine, and most of what is retained is concentrated in the thyroid. If, therefore, we give a dose of radioiodine having measured its radioactivity, and collect the urine excreted for the next forty-eight hours and determine its total radioactivity, we can calculate the proportion of the ingested radioiodine that has been lost from the body, and therefore the proportion that has been retained by the thyroid. But since the thyroid cannot distinguish radioiodine from normal iodine, this is a valid measure of the iodine avidity of the gland (Skanse, 1949; Fraser and others, 1953) . This is a simple measurement, taking perhaps ten minutes to perform, and the radioactivity of liquids can be determined with ease and sensitivity, so that small doses can be used.
But you may say that you do not wish to rely on the complete collection of urine and that you want to estimate the thyroxine output rather than merely the iodine uptake of the gland. Suppose, therefore, that a known dose of radioiodine is given, and forty-eight hours later a plasma sample is taken. If we precipitate the thyroxine content of this plasma with a protein precipitant, and measure the radioactivity of this precipitate, we can deduce the amount of our radioiodine which, in the intervening two days, has been incorporated into thyroxine and discharged into the plasma. In normal subjects, less than 0.4 per cent. of the dose is protein-bound by this time as thyroxine per litre of plasma, whereas higher concentrations of up to 5 per cent. per litre are regularly reached in hyperthyroidism, owing to the more rapid thyroxine production in this condition (Goodwin and others, 1951) . We may recognise from this test certain merits of the isotope technique: we give our radioiodine by mouth and identify its arrival in the plasma; we determine its actual concentration in plasma and, by simple fractionation, its concentration in a particular chemical form; and, since we know the moment and the only moment at which this type of iodine was given, we can establish a value for the rate of synthesis of the radioactive thyroxine and therefore of thyroxine as a whole, since the two forms of iodine are indistinguishable chemically and metabolically.
It is clear that measurements of this kind have a wide application in clinical medicine, and many are already being used. Radioactive iron may be given orally in different chemical forms (Moore and others, 1944) or in different types of 20
anawiiia (Dubach and others, 1948) , and its efficiency of absorption estimated from plasma samples; or radioiron given intravenously, to measure its degree and speed of incorporation into hvemoglobin and the red cell (Finch and others, 1949) . Red cells can be made recognisable by labelling with radioactive phosphorus (Reeve and Veall, 1949) , chromium or iron (Gibson and others, 1946) , and injected intravenously in known amounits so that the blood volume, the total red cell volume of the blood, can be deduced from the radioactivity of blood samples withdrawn after circulatory mixing has occurred. The same principle allows the total exchangeable sodium or potassium of the body, for example, in Addison's disease, to be measured, by allowing a known quantity of the appropriate isotope, radiosodium or radiopotassium, to mix throughout the body, and then establishing its concentration in a sample of plasma. The procedure is indeed widely applicable to measuring the absorption of any suitable element, for example, through the wall of the gut, the skin or the capillaries, and into the plasma, the urine, the C.S.F. or the amniotic fluid; and many such uses have been developed (Low-Beer, 1950 operation, the isotope is found to be well concentrated in bone from the head of the femur, it indicates that there must be an adequate circulation to the femoral head, but if not, the head is likely to have inadequate circulation and avascular necrosis will probably occur later (Tucker, 1950) .
By an obvious extension of this method, radiophosphorus is proving of value during operations for cerebral tumour. Probably because of their higher cellularity and vascularity, many such tumours are found to develop higher concentrations of phosphorus, and therefore of radiophosphorus, than normal cerebral tissue. If a patient has receivedl radiophosphorus before operation, the higher radioactivity of tumour than normal tissue can be recognised if a probe incorporating a counter is passed into it (Selverstone and others, 1949) . Morley and Jefferson (1952) can not only be detected, but can be measured and followed quantitatively by a Geiger counter placed in front of the neck opposite the gland. Moreover, if this counter is suitably shielded with lead, it will measure radiations from radioiodine in the thyroid, but those from radioiodine in other positions will be stopped by the lead. The Geiger counter itself consists simply of a glass tube containing two wires with a potential difference between them, but insulated from each other so that normally no current flows. When, however, a radiation from a disintegrating atom passes through the tube, it momentarily ionises the gas in the tube and a brief current flows. The frequency with which such currents flow thus correspolds with the number of atoms disintegrating, which in turn is proportional to the amount of the radioactive isotope present. So the counting rate varies simply with the amount of radioiodine in the thyroid and, with suitable calibration (Myant and others, 1949) , can be expressed as a given percentage of the dose in the gland at the time.
May I illustrate this method by a test we use in the diagnosis of hyperthyroidism (Pochin, 1950) ? l'he patient drinks a small dose of a radioiodine solution. Two hours later she returns and measurements are made with a counter opposite the neck, and opposite some other body area such as the thigh. Now, clearly, the more active the thyroid, the more radioiodine will have been taken up by the thyroid in these two hours, and the less will be left in the rest of the body, as indicated by the thigh. A simple ratio of the neck to the thigh counting rate seems in fact to give as useful diagnostic information as the basal metabolic rate, being greatlIy raised above normal in most hyperthyroid patients. The test involves about five minutes' measurements in the out-patient clinic. Even the (lose need not be calibrated exactly, since the result depends simply on a ratio of two counting rates measuring the proportion of the close that is in the thyroid to that which is left in the rest of the body two hours after administration. And the radiation received by the thyroid is comparable to that received by the whole abdomen during the barium meal examination.
Many other applications of external counting have been or are being developedtiming the rate of venous flow by injecting radiosodium at the ankle ancd recording its arrival at the groin (Payling WVright and others, 1948); timing the absorption of drugs fronm an injection site (Reiner and others, 1943) ; studying the lymphatic removal of colloid or protein ml-aterial; and measurement of circulation time from one ventricle of the heart to the other (Prinzmetal and others, 1949) . Or if radiosodium is injected into a pedicle skin flat (Barron and others, 1951) and is found to be rapidly removed through one end of the pedicle, an efficient circulation must have been established through this end; and by detecting the vascularisation of flaps in this way the transfer and establishment of such grafts can be safely accelerated, and the patient's stay in hospital and in plaster is often more than halved by using this test.
It is an obvious extension of these measurements of the total amount of radioisotope in a given region to map out in more detail how it is distributed within the region. This requires rather higher doses of radioisotope and shielding of the counter so that the amount of isotope under the skin at each point can be measured without interference from that in adjacent areas. With suitable equipment and quite moderate dosage, it is easy to map the outlines of a retrosternal goitre (Fig. 1) , the process involving perhaps twenty minutes' work, a few days after administration of a test dose. It may also be useful to determine in this way the size of the thyroid, the activity of different parts of the gland, and even sometimes its position in the neck in those hyperthyroid patients requiring thyroidectomy, but in whom the gland is not palpable (Fig. 2) . Although most techniques of mapping are concerned with radioiodine and thyroid tissue, several such procedures are of value in the control of other types of radioisotope treatment as will be discussed later; and the method is of wide application. Certain cerebral tumours concentrate diiodofluorescein, of which the iodine, if radioactive, may be detected by counters external to the skull, although at present without great accuracy (Belcher and others, 1952) . The placental site can be identified in placenta prwevia if the circulating blood is labelled with radiosodium (Browne and Veall, 1950), and it is reported that the utilisation of oral iron in bone marrow or in the body iron stores may be followed by counts over livrer, spleen and bones after ingestion of radioiron.
It appears, therefore, that the radioisotopes offer a versatile range of methods for examining many funct;ions of the living body without significant radiation hazard. Whether these depend upon fluids removed from the body, or on biopsy, or on external counts over the body, the measurements can be strictly quantitative, 23 thev refer to material administered at a known time and they sample the normal body metabolism without disturbing it, thanks to the sensitivity of the detection methods and the small doses of isotope that can be given.
When, however, we turn to the therapeutic applications of the radioactive isotopes the emphasis is entirely different, although the underlying principles are the same. We are now seeking, as in all radiotherapy, to achieve intense radiation where it is required, with as little radiation as possible elsewhere in the body. Now with almost all the isotopes used therapeutically, it is the beta radiation which is responsible for most of the radiotherapeutic effect, and this is due to the emission of electrons which penetrate at most a few millimetres through tissue, so that the tissue destruction is largely confined to the actual areas in which the isotope is concentrated. This gives us two possibilities-either of irradiating a surface by producing a high concentration of radioactive material over that surface; or of irradiating a tissue mass by isotopes distributed throughout that mass. In each case we require to achieve a high local concentration of isotope, with as little of the isotope as possible circulating in the rest of the body. The irradiation of surfaces is proving clinically valuable in several ways. Simple and effective beta radiation applicators to the skin can be obtained using radioactive phosphorus. Similar possibilities arise with internal surfaces and radioactive materials are being used within latex bags introduced into the bladder to irradiate papillary carcinoma of the bladder (Walton and Sinclair, 1952) . Nor need the containing sac be an artificial one, for it is found that colloidal materials introduced into the peritoneal or pleural cavity only escape slowly through the peritoneum or pleura. If a colloidal suspension of radiogold is injected intraperitoneally, it sediments rapidly (Fig. 3) and fairly uniformly on to the peritoneal surface, an(i most of it remains there or just below the surface during the whole period of its effective radioactivity-a little passing to the regional lymph glands but negligible amounts to the blood or body as a whole. In patients with rapidly recurring malignant ascites, due to deposits of peritoneal carcinoma, intraperitoneal radiogold will produce an intense local radiation largely confined to the peritoneal surface, and may abolish the formation of ascites which is the main initial limitation on health in some patients. Since the radiation only penetrates a millimetre or %Concentration / litre. so from the peritoneal surface, this treatment can only be palliative where substantial carcinomatous masses are present. It might, however, be curative where seedling deposits only were present, as after the operative rupture of a malignant ovarian cyst. Radiogold has a similar value when given intrapleurally for recurrent pleural effusion of malignant origin, and we have reduced the frequency of aspiration in one such case from daily to three-weekly aspiration from each pleural cavity. Radioactive gold undergoes radioactive decay rather rapidly, and delivers most of its radiation in the first few days from the time of its injection. Even when injected subcutaneously in the region of a tumour, it therefore remains at the site of injection for long enough to be valuable therapeutically (Hahn, 1951) in much the same way as with radium or radon implantations, but often with a better and more uniform dose distribution within the affected tissues, and such removal as occurs up the lymphatics from the affected area may in itself be helpful. Attempts are being made to treat carcinoma of the prostate by local injection through a cystotomy (Flocks and others, 1902) , and bronchial carcinoma by local injection into the bronchus (Hahn and Carothers, 1951) . Now you will notice that we have so far been discussing therapeutic methods in which the isotope is placed in apposition with the tumour or affected tissue. But in some circumstances if we administer a suitable preparation of isotope, we can leave the body to concentrate it in the right positions, on account either of the physical or of the chemical properties of the preparation used. Fig. 4 Map of colloidal radiogold concentration in the chest after intravenous injection of a large particle suspension, indicating selective concentration in the lungs. Data in a case of pulmonary adenocarcinomatosis.
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Concentration, based on physical properties, has more interest and promise than immediate value. If a suspension of colloidal material, say radiogold, is injected into a systemic vein, it will be carried by the circulation through the heart, but if the particle size is sufficiently large, the particles will be unable to pass through the lung capillaries and the radioactive substance will remain localised in the lungs. We have attempted to treat a patient with multiple adeno-carcinomatosis of the lungs in this way and obtained a high concentration of isotope within the lungs (Fig. 4) with no detectable escape to other parts of the body, although we did not achieve a sufficient dose to influence the tumour growth (Pochin, 1951) .
Or, if colloidal gold is given intravenously in small particle size, the particles are removed by the reticulo-endothelial system and become concentrated mainly in the liver. Fig. 5 shows the distribution of radiogold achieved in this way in a patient with a primary hepatoma where again a selective but still inadequate local concentration was reached in the liver. This technique has been used with colloidal preparations of various radioisotopes using the oxide of radioactive manganese and chromic radiophosphate as well as radiogold, in chronic leukemias and Hodgkin's disease, but without outstanding success.
,- At present, the most valuable methods depend upon chemical localisation of the isotope-of radioiodine for hyperthyroidism and certain thyroid carcinomata and of radiophosphorus for polycythemia.
It is well known that iodine reaches a concentration in the thyroid which is several hundred times that in the body as a whole. Since this holds equally for radioiodine, it follows that the thyroid can be given destructive irradiation of several thousand rcentgens with an amount of radioiodine that is trivial in its effects on the body as a whole. The thyroid overactivity in Graves's disease can thus be abolished very simply by a suitable dose of radioiodine-a most attractive treatment to the patient who is spared the need for operation or for prolonged supervision during the administration of thiouracil. She simply takes what appears to be a drink of cold water-for the amount of the iodide in a millicurie is less than a hundredth of a microgram and quite unnoticeable-and, if she is still thyrotoxic two months later, another drink.
This apparent simplicity is, perhaps, deceptive, and for three reasons. Firstly, these isotopes are somewhat hazardous to handle in therapeutic amounts, highly 27 specialised equipment is required in the control of dosage, and some care is needed in dealing with the radioactive urine which is passed for the first days after the dose. Secondly, our methods of calculating the necessary dose are not yet precise, largely owing to differing radio-sensitivity of different glands; and a rcentgen dosage which will fail to abolish the toxicity of one gland may induce myxcedema in the next. And thirdly, we do not yet know that the risks of carcinogenesis from this form of treatment are negligible. Radioiodine was first used in the United States in the treatment of Graves's disease over ten years ago, and several thousand patients have now been treated without evidence of carcinogenesis, nor was this a consequence of the earlier radiotherapeutic treatment of this condition. Since, however, such tumours might not arise until after a latency of perhaps twenty years, we shall not know for certain for another ten years whether the risk is negligible. If, then, the risk turns out to be over 1 per cent., the treatment should rarely be used unless both surgery and thiouracil therapy are attended by serious hazards to life; but if the risk of carcinogenesis is less than, say 0.1 per cent., radioiodine may well offer the treatment of choice in Graves's disease, unless by then we have achieved a less barbarous therapy than by mutilating the overstimulated gland. Meanwhile, I think that this treatment should be used whenever both thiouracil and surgery are impossible or hazardous, and particularly in patients over 45, in whom the expectation of life is in any case comparable with the twenty years' latency of any possible carcinogenesis. When we turn to the radioiodine treatment of thyroid carcinoma, of course, this consideration of possible carcinogenesis loses its weight, and here I think that radioiodine therapy is clinically obligatory in certain cases. We require to be able to select those tumours of which the cells or follicles concentrate iodine, since they will then concentrate radioiodine and may be destroyed by the intense local radiation that will result. The clearest initial guide in the selection of patients for this treatment appears to-lie in the histological pattern of the tumour (Fitzgerald and Foote, 1949) . For anaplastic thyroid carcinomata, radioiodine is unlikely to be helpful, because such tumours do not usually appear to concentrate and retain iodine, although some have been shown to do so. It is those tumours which are histologically well differentiated, with colloid-filled alveoli resembling normal thyroid tissue, which are also biochemically well differentiated and resemble normal thyroid tissue in concentrating and retaining radioiodine, although rarely as efficiently as does the normal gland. Unfortunately, this radioiodine concentration in the tumour is rarely present or demonstrable while the normal thyroid is functioning. Only after the removal or destruction of the thyroid gland does the tumour take over this function and become accessible to treatment with radioiodine. hiave occturred in our experience of about a hundred 100 mC doses. The nursing and laboratory staff, however, who may be dlealing with several hundred millicuries a week, will require to observe certain rather strict precautions in their work if their radiationi exposure is to be kept to the accepted low permissible figures regal cled as safe for continuing exposure. WVe have found that a comnbination of quite simple methods will prevent any undue exposure-involving nothing more exacting than the methods of a bacteriologist handling pathogens, a surgeon handling radium, andl sonme of the routine methods of barrier nursing. On this basis the patient may, if necessary, be nursed in a general ward with normal bed spacing and without restriction as to visitors, but nurses should use rubber gloves for the care of such patients, or anv handling of their bedpans, in the first week from the dose, an(l uirine may require to be kept for periods of up to eight weeks before its radioactivity is low enough to permit its rejection. The laboratory precautions require to be even more punctilious, since the (lose is received in a solution of wxhich the accidental ing-estion should not on anv day exceed one twentythousanditlh of a millilitre, and the day's permissible radiationi would be received within one secoll(l by ain part of the bodv within half an inch of a 100 mC dose.
The opportunLities for therapy w%ith radlioiodinie are unusually favourable, since the element may be highly concentrated in the tissue which requires treatment.
The control of polycvthemia by repeatedi (loses of radiophosphorus (Stroebel and Hall, 1951) Here is an open field for imaginative planning and detailed biochemistry, and the therapeutic applications of the radioactive isotopes offer as fertile a ground for investigation as their diagnostic uses. Twenty years ago this chapter in medical investigation had not opened. To-day I think we are still at the beginning of the chapter. REFERENCES. BARRON, J. N., VEALL, N., and ARNOTT, D. G. (1951) . Brit. J. plast. Surg., 4, 16.
